Empirical anidulafungin therapy increases the treatment efficacy in invasive candidiasis: ERA study results (EraxisR in the Russian Federation)
The objective of the study was to evaluate the effectiveness of empirical therapy with anidulafungin in patients with invasive candidiasis in real clinical practice in Russian healthcare institutions.Materials and methods. In a prospective multicenter (n = 23) ERA study in 2015–2017, 92 adult patien...
Main Author: | N. N. Klimko |
---|---|
Format: | Article |
Language: | Russian |
Published: |
ABV-press
2019-10-01
|
Series: | Онкогематология |
Subjects: | |
Online Access: | https://oncohematology.abvpress.ru/ongm/article/view/374 |
Similar Items
-
Pharmacoeconomic analysis of the anidulafungin (EraxisR) in adult patients with invasive candidiasis
by: S. V. Nedogoda, et al.
Published: (2019-10-01) -
Early Empirical Anidulafungin Reduces the Prevalence of Invasive Candidiasis in Critically Ill Patients: A Case-control Study
by: Hasan Md Jahidul, et al.
Published: (2022-05-01) -
In vitro anidulafungin activity against yeasts – system and disseminated mycosis pathogens
by: A. B. Kulko
Published: (2015-10-01) -
Multicenter Analysis of Anidulafungin Use in Invasive Candida Infections
by: Meltem Işıkgöz Taşbakan, et al.
Published: (2019-06-01) -
Multidrug-resistant Candida glabrata strains obtained by induction of anidulafungin resistance in planktonic and biofilm cells
by: Camila Hatwig, et al.
Published: (2019-12-01)